Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 27;12(4):372.
doi: 10.3390/v12040372.

Virology, Epidemiology, Pathogenesis, and Control of COVID-19

Yuefei Jin  1 , Haiyan Yang  1 , Wangquan Ji  1 , Weidong Wu  2 , Shuaiyin Chen  1 , Weiguo Zhang  1   3 , Guangcai Duan  1
Affiliations
Review

Virology, Epidemiology, Pathogenesis, and Control of COVID-19

Yuefei Jin et al. Viruses. .

Abstract

The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiology and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection. As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health. To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review.

Keywords: COVID-19; SARS-CoV-2; epidemiology; pathogenesis; therapeutics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Geographic location of Wuhan, Hubei Province in China. Hubei Province is located in the central area of China, and the provincial capital is Wuhan.
Figure 2
Figure 2
β-coronavirus particle and genome [9] (A) The β-coronavirus particle. β-coronavirus is an enveloped, nonsegmented, positive-sense single-stranded RNA virus genome in a size ranging from 29.9 kb. The virion has a nucleocapsid composed of genomic RNA and phosphorylated nucleocapsid (N) protein, which is buried inside phospholipid bilayers and covered by the spike glycoprotein trimmer (S). The membrane (M) protein hemagglutinin-esterase (HE) and the envelope (E) protein are located among the S proteins in the virus envelope. (B) 5′ and 3′ terminal sequences of the SARS-CoV-2 genome. The gene order is 5′-replicase ORF1ab-S-envelope(E)-membrane(M)-N-3′. ORF3ab, ORF6, ORF7ab, ORF8, ORF9ab, and ORF10 are located at the predicted positions shown in the picture. 1a, 1b, 3a, 3b, 6, 7a, 7b, 8, 9a, 9b, 10 in the picture represent different ORF genes.
Figure 3
Figure 3
Ecology of emerging coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 are all bat origin coronaviruses, which cause human infections after circulation in animal hosts of civet, camel, and pangolin.
Figure 4
Figure 4
Spatiotemporal distribution of COVID-19. (A) The spread and decline of COVID-19 in mainland China over time. The time point (red words) of “0” new confirmed case first reported in Hubei Province was 18 March, 2020. (B) Distribution of cases with different onset times before 11 February 2020.
Figure 5
Figure 5
Postulated pathogenesis of SARS-CoV-2 infection. Antibody-dependent enhancement (ADE); ACE2: angiotensin-converting enzyme 2; RAS: renin-angiotensin system; ARDS: acute respiratory distress syndrome. Red words represent the important turning points in SARS-CoV-2 infection.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., Ren R., Leung K.S.M., Lau E.H.Y., Wong J.Y., et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2001316. - DOI - PMC - PubMed
    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed
    1. World Health Organization Press Conference The World Health Organization (WHO) Has Officially Named the Disease Caused by the Novel Coronavirus as COVID-19. [(accessed on 11 February 2020)]; Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
    1. Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses—A statement of the Coronavirus Study Group. bioRxiv. 2020 doi: 10.1101/2020.02.07.937862. - DOI
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (Lond. Engl.) 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed

MeSH terms